Loading...
Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project
Background and Objectives: The Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine has demonstrated excellent efficacy and safety in phase 3 trials. However, no dialyzed patients were included, and therefore safety data for this patient group is lacking. The aim of the study was to assess the safety an...
Na minha lista:
| Udgivet i: | Medicina (Kaunas) |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307559/ https://ncbi.nlm.nih.gov/pubmed/34357013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57070732 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|